Class IIOngoingD-0614-2020
Drug recall · December 18, 2019
Ranitidine Syrup Oral Solution 15 mg/mL 6. fl. oz recall
Why: CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Ranitidine Syrup Oral Solution 15 mg/mL 6. fl. oz. (473 mL), NDC 65162-664-90.
- Lots / codes
06648001A 11/2019 06648003A 4/2020 06649001A 1/2021
- Quantity
- N/A
- Company
- Amneal Pharmaceuticals, Inc., Brookhaven, NY
- Distribution
- Product was distributed throughout the United States.
- Initiated
- November 22, 2019 · Voluntary: Firm initiated
- Classified
- December 9, 2019
- Reported
- December 18, 2019
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IIOngoingDec 18, 2019Ranitidine TabletsAmneal Pharmaceuticals, Inc. · D-0612-2020Class IIOngoingDec 18, 2019Ranitidine TabletsAmneal Pharmaceuticals, Inc. · D-0613-2020Class IIOngoingDec 18, 2019Ranitidine TabletsAmneal Pharmaceuticals, Inc. · D-0615-2020Class IIOngoingDec 18, 2019Ranitidine TabletsAmneal Pharmaceuticals, Inc. · D-0616-2020
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ranitidine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.